Eubiologics
Seoul, Korea, Republic of
Purpose
to test malaria immunogen sequences and EuBiologics’ adjuvant platform for the generation of malaria elimination vaccine candidates for the world’s poorest populations and to explore novel adjuvant platforms.
Division
Global Health
Date
November 2025
Region Served
GLOBAL
Committed amount
$1,586,122
Grant topic
Discovery and Translational Sciences
Duration (months)
20
Grantee location
Seoul, Korea, Republic of
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.